ADC Therapeutics
Karen Russo is a seasoned pharmaceutical executive with extensive experience in leadership roles across various organizations. Currently serving as Vice President and Global Program Head at ADC Therapeutics since December 2022, Russo previously held key positions at Vertex Pharmaceuticals, Novartis, and Pfizer. Notable roles at Novartis include Vice President and Global Disease Lead for Benign Hematology, as well as multiple director and executive positions in CAR-T marketing. Russo's career began in sales with Pfizer, showcasing a progressive trajectory through marketing and leadership. Russo holds a Bachelor of Arts in Psychology from Clemson University.
This person is not in any teams
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.